Business Paid
Neuca to buy a 72.6% stake in US OncoBay for $33.5 mln
13:40
Neuca Clinical Trials, a subsidiary of the Polish pharmaceutical company Neuca, has signed a conditional agreement to buy 72.6% stake in OncoBay Clinical for a total of USD 33.5 million.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
